 Eric Keller
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology, Interventional | 15 | 2023 | 49 | 6.790 |
Why?
| | Radiologists | 10 | 2024 | 61 | 4.290 |
Why?
| | Radiography, Interventional | 7 | 2020 | 130 | 3.760 |
Why?
| | Informed Consent | 6 | 2023 | 198 | 2.310 |
Why?
| | Specialization | 5 | 2024 | 136 | 2.060 |
Why?
| | Interdisciplinary Communication | 5 | 2019 | 197 | 1.300 |
Why?
| | Medical Futility | 3 | 2020 | 31 | 1.280 |
Why?
| | Leiomyoma | 2 | 2022 | 59 | 1.170 |
Why?
| | Uterine Neoplasms | 2 | 2022 | 97 | 1.130 |
Why?
| | Competitive Behavior | 2 | 2019 | 43 | 1.100 |
Why?
| | Conflict of Interest | 4 | 2024 | 53 | 1.090 |
Why?
| | Attitude of Health Personnel | 8 | 2020 | 1186 | 1.020 |
Why?
| | Embolization, Therapeutic | 2 | 2022 | 242 | 1.010 |
Why?
| | Physicians | 5 | 2021 | 940 | 0.990 |
Why?
| | Practice Patterns, Physicians' | 3 | 2022 | 1358 | 0.890 |
Why?
| | Uterine Myomectomy | 2 | 2022 | 7 | 0.850 |
Why?
| | Hysterectomy | 2 | 2022 | 138 | 0.780 |
Why?
| | Academic Medical Centers | 4 | 2019 | 548 | 0.760 |
Why?
| | Imaging, Three-Dimensional | 2 | 2016 | 583 | 0.740 |
Why?
| | Cyclobutanes | 1 | 2022 | 8 | 0.730 |
Why?
| | Truth Disclosure | 2 | 2020 | 50 | 0.720 |
Why?
| | Education, Medical | 4 | 2023 | 276 | 0.710 |
Why?
| | Colitis, Ulcerative | 1 | 2022 | 148 | 0.630 |
Why?
| | Ethics, Research | 1 | 2020 | 32 | 0.630 |
Why?
| | Perception | 2 | 2020 | 377 | 0.620 |
Why?
| | Health Literacy | 1 | 2022 | 184 | 0.620 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 335 | 0.610 |
Why?
| | Endovascular Procedures | 3 | 2024 | 384 | 0.600 |
Why?
| | Ethics, Clinical | 1 | 2019 | 9 | 0.600 |
Why?
| | Compensation and Redress | 1 | 2019 | 8 | 0.600 |
Why?
| | Stents | 3 | 2020 | 556 | 0.600 |
Why?
| | Vascular Diseases | 2 | 2020 | 251 | 0.590 |
Why?
| | Health Facility Administrators | 1 | 2019 | 6 | 0.590 |
Why?
| | Work Engagement | 1 | 2019 | 14 | 0.580 |
Why?
| | Global Health | 1 | 2022 | 401 | 0.580 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 31 | 0.580 |
Why?
| | Job Description | 1 | 2018 | 12 | 0.580 |
Why?
| | Enediynes | 1 | 2018 | 1 | 0.560 |
Why?
| | Image-Guided Biopsy | 1 | 2018 | 41 | 0.560 |
Why?
| | Vascular Access Devices | 1 | 2018 | 30 | 0.560 |
Why?
| | Veins | 1 | 2018 | 68 | 0.550 |
Why?
| | Occupational Stress | 1 | 2019 | 46 | 0.550 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2017 | 285 | 0.540 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 171 | 0.540 |
Why?
| | Referral and Consultation | 3 | 2022 | 853 | 0.530 |
Why?
| | Hypersplenism | 1 | 2017 | 9 | 0.520 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 119 | 0.520 |
Why?
| | Ultrasonography, Interventional | 1 | 2019 | 160 | 0.520 |
Why?
| | Humans | 46 | 2024 | 144957 | 0.510 |
Why?
| | Palliative Care | 3 | 2022 | 1008 | 0.510 |
Why?
| | Organometallic Compounds | 1 | 2018 | 112 | 0.510 |
Why?
| | Splenic Vein | 1 | 2016 | 2 | 0.510 |
Why?
| | Splanchnic Circulation | 1 | 2016 | 13 | 0.500 |
Why?
| | Splenic Artery | 1 | 2016 | 13 | 0.500 |
Why?
| | Radiation Dosage | 1 | 2018 | 193 | 0.500 |
Why?
| | Cardiac Imaging Techniques | 1 | 2016 | 24 | 0.490 |
Why?
| | Terminology as Topic | 1 | 2018 | 255 | 0.490 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 62 | 0.490 |
Why?
| | Patient Care Team | 2 | 2019 | 689 | 0.490 |
Why?
| | Perfusion Imaging | 1 | 2016 | 65 | 0.490 |
Why?
| | Arteriovenous Fistula | 1 | 2016 | 38 | 0.480 |
Why?
| | Interprofessional Relations | 1 | 2019 | 281 | 0.480 |
Why?
| | Patients | 1 | 2018 | 182 | 0.480 |
Why?
| | Magnetic Resonance Imaging | 3 | 2017 | 3869 | 0.470 |
Why?
| | Abdomen | 1 | 2016 | 141 | 0.470 |
Why?
| | Professional Role | 1 | 2017 | 158 | 0.460 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2019 | 1416 | 0.460 |
Why?
| | Myocardial Contraction | 1 | 2017 | 298 | 0.450 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 214 | 0.450 |
Why?
| | Electrocardiography | 1 | 2019 | 663 | 0.450 |
Why?
| | Health Care Costs | 1 | 2019 | 427 | 0.450 |
Why?
| | Workflow | 1 | 2016 | 185 | 0.450 |
Why?
| | Spleen | 1 | 2017 | 508 | 0.440 |
Why?
| | Temperature | 1 | 2018 | 679 | 0.440 |
Why?
| | Liver Cirrhosis | 1 | 2017 | 288 | 0.430 |
Why?
| | Medical Oncology | 1 | 2018 | 332 | 0.430 |
Why?
| | Heart Valve Prosthesis | 1 | 2016 | 134 | 0.430 |
Why?
| | Catheter Ablation | 1 | 2018 | 353 | 0.430 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 251 | 0.430 |
Why?
| | Gynecology | 1 | 2017 | 178 | 0.420 |
Why?
| | Patient Preference | 1 | 2017 | 225 | 0.420 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 15 | 0.420 |
Why?
| | Hemodynamics | 2 | 2017 | 1121 | 0.420 |
Why?
| | Ambulatory Care | 1 | 2019 | 603 | 0.410 |
Why?
| | Internship and Residency | 2 | 2023 | 1257 | 0.410 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 286 | 0.400 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 392 | 0.400 |
Why?
| | Liver Diseases | 1 | 2016 | 304 | 0.400 |
Why?
| | Health Policy | 1 | 2017 | 401 | 0.400 |
Why?
| | Biomedical Research | 1 | 2020 | 710 | 0.400 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 541 | 0.390 |
Why?
| | Vascular Surgical Procedures | 1 | 2017 | 340 | 0.390 |
Why?
| | Female | 23 | 2022 | 78376 | 0.390 |
Why?
| | Aorta | 1 | 2016 | 430 | 0.390 |
Why?
| | Interviews as Topic | 4 | 2018 | 901 | 0.380 |
Why?
| | Aortic Valve | 1 | 2016 | 365 | 0.380 |
Why?
| | Fellowships and Scholarships | 1 | 2017 | 357 | 0.380 |
Why?
| | Quality of Health Care | 1 | 2018 | 693 | 0.380 |
Why?
| | End Stage Liver Disease | 1 | 2013 | 94 | 0.370 |
Why?
| | Adipocytes | 1 | 2014 | 223 | 0.370 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2015 | 180 | 0.360 |
Why?
| | Paracentesis | 2 | 2022 | 16 | 0.360 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 781 | 0.360 |
Why?
| | Surgeons | 1 | 2017 | 340 | 0.360 |
Why?
| | Male | 19 | 2022 | 72406 | 0.350 |
Why?
| | Predictive Value of Tests | 4 | 2019 | 2118 | 0.350 |
Why?
| | Software | 1 | 2017 | 692 | 0.340 |
Why?
| | Melanoma | 1 | 2018 | 761 | 0.340 |
Why?
| | Quality Improvement | 1 | 2020 | 1291 | 0.330 |
Why?
| | Adult | 13 | 2022 | 40506 | 0.310 |
Why?
| | Physician-Patient Relations | 3 | 2020 | 588 | 0.310 |
Why?
| | Middle Aged | 12 | 2022 | 35928 | 0.310 |
Why?
| | Delivery of Health Care | 1 | 2017 | 947 | 0.310 |
Why?
| | Tissue and Organ Procurement | 1 | 2013 | 346 | 0.300 |
Why?
| | Public-Private Sector Partnerships | 2 | 2020 | 44 | 0.300 |
Why?
| | Decision Making | 1 | 2017 | 980 | 0.300 |
Why?
| | Diffusion of Innovation | 2 | 2020 | 98 | 0.290 |
Why?
| | Students, Medical | 1 | 2014 | 375 | 0.290 |
Why?
| | Time Factors | 6 | 2020 | 7183 | 0.280 |
Why?
| | Computed Tomography Angiography | 3 | 2019 | 145 | 0.280 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2738 | 0.270 |
Why?
| | Policy Making | 2 | 2019 | 82 | 0.260 |
Why?
| | Mental Health | 1 | 2014 | 792 | 0.250 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2197 | 0.250 |
Why?
| | Liver Transplantation | 1 | 2013 | 823 | 0.240 |
Why?
| | Trust | 2 | 2019 | 153 | 0.240 |
Why?
| | Cell Differentiation | 1 | 2014 | 2050 | 0.240 |
Why?
| | Cooperative Behavior | 2 | 2019 | 465 | 0.220 |
Why?
| | Ascites | 2 | 2022 | 49 | 0.220 |
Why?
| | Lung | 1 | 2018 | 4109 | 0.220 |
Why?
| | Retrospective Studies | 10 | 2022 | 17101 | 0.210 |
Why?
| | Vascular Patency | 3 | 2020 | 121 | 0.210 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 359 | 0.210 |
Why?
| | Health Care Sector | 2 | 2024 | 26 | 0.210 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 6053 | 0.200 |
Why?
| | Aged | 7 | 2022 | 25947 | 0.190 |
Why?
| | Cost-Benefit Analysis | 3 | 2022 | 636 | 0.190 |
Why?
| | Treatment Outcome | 5 | 2019 | 11695 | 0.180 |
Why?
| | Resuscitation Orders | 1 | 2022 | 48 | 0.180 |
Why?
| | Prospective Studies | 3 | 2022 | 7997 | 0.180 |
Why?
| | Phlebography | 2 | 2019 | 39 | 0.180 |
Why?
| | Chicago | 2 | 2019 | 61 | 0.180 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 248 | 0.170 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 117 | 0.170 |
Why?
| | Social Media | 1 | 2024 | 171 | 0.170 |
Why?
| | Testosterone | 2 | 2015 | 419 | 0.170 |
Why?
| | Radiology | 1 | 2023 | 175 | 0.160 |
Why?
| | Patient Care Planning | 1 | 2022 | 170 | 0.160 |
Why?
| | Superior Vena Cava Syndrome | 1 | 2020 | 4 | 0.160 |
Why?
| | Genital Neoplasms, Female | 1 | 2022 | 99 | 0.160 |
Why?
| | Vena Cava, Superior | 1 | 2020 | 25 | 0.160 |
Why?
| | United States | 6 | 2024 | 15988 | 0.150 |
Why?
| | May-Thurner Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1563 | 0.150 |
Why?
| | Iliac Vein | 1 | 2019 | 15 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2020 | 81 | 0.150 |
Why?
| | Angioplasty, Balloon | 1 | 2020 | 94 | 0.150 |
Why?
| | Interinstitutional Relations | 1 | 2019 | 53 | 0.150 |
Why?
| | Culturally Competent Care | 1 | 2020 | 74 | 0.140 |
Why?
| | Salaries and Fringe Benefits | 1 | 2019 | 60 | 0.140 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2018 | 21 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2017 | 3415 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1135 | 0.140 |
Why?
| | Professional-Family Relations | 1 | 2020 | 153 | 0.140 |
Why?
| | Signal-To-Noise Ratio | 1 | 2018 | 73 | 0.140 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2019 | 98 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 97 | 0.140 |
Why?
| | Decision Support Techniques | 1 | 2022 | 456 | 0.140 |
Why?
| | Comprehension | 1 | 2020 | 180 | 0.130 |
Why?
| | Communication | 2 | 2023 | 967 | 0.130 |
Why?
| | Hyperthermia, Induced | 1 | 2018 | 121 | 0.130 |
Why?
| | Philosophy, Medical | 1 | 2017 | 8 | 0.130 |
Why?
| | Uterine Artery Embolization | 1 | 2017 | 9 | 0.130 |
Why?
| | Grounded Theory | 1 | 2017 | 46 | 0.130 |
Why?
| | Medicare | 2 | 2022 | 887 | 0.130 |
Why?
| | Automation | 1 | 2017 | 102 | 0.120 |
Why?
| | Equipment Design | 1 | 2018 | 530 | 0.120 |
Why?
| | Interview, Psychological | 1 | 2017 | 94 | 0.120 |
Why?
| | Hypertension, Portal | 1 | 2017 | 66 | 0.120 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 557 | 0.120 |
Why?
| | Career Choice | 1 | 2018 | 237 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 349 | 0.120 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2016 | 9 | 0.120 |
Why?
| | Observer Variation | 1 | 2017 | 355 | 0.120 |
Why?
| | Risk Assessment | 3 | 2020 | 3676 | 0.120 |
Why?
| | DNA Repair | 1 | 2018 | 256 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2016 | 215 | 0.110 |
Why?
| | Image Enhancement | 1 | 2016 | 199 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | DNA Damage | 1 | 2018 | 430 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2018 | 8279 | 0.110 |
Why?
| | Blood Flow Velocity | 1 | 2016 | 413 | 0.110 |
Why?
| | Embryonic Development | 1 | 2015 | 125 | 0.110 |
Why?
| | Stress, Mechanical | 1 | 2017 | 494 | 0.110 |
Why?
| | Empathy | 1 | 2017 | 182 | 0.110 |
Why?
| | PPAR delta | 1 | 2014 | 6 | 0.110 |
Why?
| | Regional Blood Flow | 1 | 2016 | 514 | 0.110 |
Why?
| | Leadership | 1 | 2019 | 409 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2014 | 17 | 0.100 |
Why?
| | ROC Curve | 1 | 2016 | 615 | 0.100 |
Why?
| | Zinc Fingers | 1 | 2014 | 53 | 0.100 |
Why?
| | Adipogenesis | 1 | 2014 | 57 | 0.100 |
Why?
| | Stroke Volume | 1 | 2017 | 651 | 0.100 |
Why?
| | Contrast Media | 1 | 2016 | 488 | 0.100 |
Why?
| | Emergency Medical Services | 1 | 2020 | 696 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 842 | 0.100 |
Why?
| | Macaca mulatta | 1 | 2014 | 191 | 0.100 |
Why?
| | Young Adult | 2 | 2022 | 14126 | 0.100 |
Why?
| | Geography | 1 | 2013 | 203 | 0.100 |
Why?
| | Ethics, Medical | 1 | 2013 | 90 | 0.100 |
Why?
| | PPAR gamma | 1 | 2014 | 177 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 265 | 0.090 |
Why?
| | Androgens | 1 | 2014 | 186 | 0.090 |
Why?
| | Disclosure | 2 | 2024 | 85 | 0.090 |
Why?
| | Patient Selection | 1 | 2016 | 719 | 0.090 |
Why?
| | Laparoscopy | 1 | 2017 | 475 | 0.090 |
Why?
| | Curriculum | 1 | 2019 | 1060 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 983 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2016 | 589 | 0.090 |
Why?
| | Waiting Lists | 1 | 2013 | 263 | 0.090 |
Why?
| | Catheters, Indwelling | 2 | 2022 | 96 | 0.090 |
Why?
| | Pilot Projects | 1 | 2017 | 1890 | 0.080 |
Why?
| | Qualitative Research | 1 | 2019 | 1671 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 543 | 0.080 |
Why?
| | Survival Analysis | 1 | 2013 | 1385 | 0.080 |
Why?
| | Risk Factors | 3 | 2020 | 10792 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3550 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 682 | 0.070 |
Why?
| | Gene Expression | 1 | 2014 | 1490 | 0.070 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2015 | 675 | 0.070 |
Why?
| | Clinical Competence | 1 | 2017 | 1244 | 0.070 |
Why?
| | Liver | 1 | 2016 | 1888 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2015 | 1241 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5872 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3335 | 0.060 |
Why?
| | Transcription Factors | 1 | 2014 | 1742 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1839 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2884 | 0.050 |
Why?
| | Neurosurgeons | 1 | 2024 | 17 | 0.050 |
Why?
| | Quality of Life | 1 | 2013 | 3192 | 0.040 |
Why?
| | Death | 1 | 2022 | 131 | 0.040 |
Why?
| | First Aid | 1 | 2020 | 14 | 0.040 |
Why?
| | Bolivia | 1 | 2020 | 61 | 0.040 |
Why?
| | Moral Obligations | 1 | 2020 | 15 | 0.040 |
Why?
| | Patient Care | 1 | 2021 | 118 | 0.040 |
Why?
| | Social Justice | 1 | 2020 | 86 | 0.040 |
Why?
| | Retreatment | 1 | 2019 | 77 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 365 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 404 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 209 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
| | Adolescent | 1 | 2017 | 22453 | 0.030 |
Why?
| | Flutamide | 1 | 2015 | 7 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 732 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1486 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2836 | 0.030 |
Why?
| | Animals | 2 | 2015 | 38109 | 0.030 |
Why?
| | Thiazolidinediones | 1 | 2015 | 139 | 0.030 |
Why?
| | Sheep | 1 | 2015 | 880 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1695 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4569 | 0.010 |
Why?
| | Pregnancy | 1 | 2015 | 7191 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 3082 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|